Home/ Stocks/ ONCO

Onconetix, Inc. Common Stock

ONCO XNAS

$1.08 -0.03 (-2.27%) ▼ 15-min delayed

Open

$1.14

High

$1.23

Low

$1.05

Volume

718.3K

Market Cap

$126.1K

About Onconetix, Inc. Common Stock

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 2 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$21.5K	$-4,214,875	$-6.71
FY 2025	$815.4K	$-14,032,342	$-16.56
Q3 2025	$303.7K	$-8,783,702	$-6.25
Q2 2025	$106.5K	$-2,372,442	$-4.76

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 12, 2026

Calendar →

TickerDaily Coverage

Why Is Onconetix, Inc. Common Stock (ONCO) Stock Down 50.3% Today?

Penny Stocks Marcus Rivera · 1d ago

Onconetix (ONCO) stock plummeted 50.3% Tuesday, May 19, 2026, dropping from $0.3057 to $0.1511 on...

View All Coverage →

Get ONCO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Onconetix, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.